200,000+ products from a single source!

sales@angenechem.com

Home > Indole Synthesis Using Silver Catalysis

Indole Synthesis Using Silver Catalysis

Aimee K. Clarke+, Hon E. Ho+, James A. Rossi-Ashton+, Richard J. K. Taylor, and William P. Unsworth*

 

 


1. Introduction
The indole core is a key structural component in many natural products and pharmaceuticals and serves as a fundamental building block in organic synthesis.[1] The synthesis of indole scaffolds has therefore been the focus of much research and a myriad of methods to construct indole rings have been developed over the years.[2] Classical methods include the Fischer indole[3] and Bartoli syntheses, which are widely and routinely used by the synthetic community.[4] Nonetheless, limitations associated with these classical procedures mean that establishing novel strategies to prepare indoles is still important and continues to be actively pursued.

 

Many indole syntheses make use of alkyne activation approaches, typically involving coordination of a metal catalyst to the alkyne to activate it towards cyclization.[5] Silver, a member of the “coinage metal” family, can be readily obtained in the form of silver(I) salts with a variety of different counterions. These salts, which have a d10 electronic configuration at silver, are well-established as being good s-/p-Lewis acids and are recognized as being powerful catalysts in alkyne activation.[6] In addition to their ability to interact with p-systems to promote useful reactivity, the use of silver in organic transformations has important economic benefits relative to other more expensive transition metals such as gold, palladium and platinum.[5,6] Indole synthesis has been extensively reviewed previously,[2] however, a comprehensive review focusing specifically on silver-catalyzed approaches has not been reported before. As the use of silver catalysis in heterocycle synthesis is becoming more prevalent,[5] a review of this topic in the context of indole synthesis is timely. To the best of our knowledge, this Minireview summarizes all silver-catalyzed indole syntheses to date, with a cut-off period of papers published before January 2019. Note that whilst we believe that all publications that feature examples within the remit of this review are discussed, we have not reproduced all of the individual examples from these
studies.

 

Many indole syntheses utilize silver in mixed catalytic systems (e.g. mixed gold/silver systems),[5] but this Minieview is limited to examples in which the silver species have been shown to be competent at catalyzing the reaction without the influence of another metal species. The review is organized in chronological order and is divided based on the type of reaction used to construct the indole core, starting with the most commonly used hydroamination pathway, before moving on to other methods. Mechanisms are included and described in more detail whenever they deviate from the generally accepted hydroamination mechanism.

 

2. Hydroamination Strategies
Alkyne hydroamination[7] is by far the most common synthetic strategy used for silver-catalyzed indole syntheses. In such reactions, anilines 1 substituted with an alkyne at their 2-position are treated with a silver(I) species which acts as a p-acid to activate the alkyne towards attack from a pendant aniline nitrogen via a 5-endo-dig cyclization mode (3!4). Protodemetallation then liberates the silver(I) species (meaning that the reactions can be catalytic in the silver species) and deprotonation completes the synthesis of the indole product 2 (Scheme 1).

 

To the best of our knowledge, the earliest example of the silver-catalyzed hydroamination strategy being used to prepare indole derivatives was reported by Rutjes and co-workers in 2004.[8] This group described the transition metal-catalyzed cyclization of o-alkynylanilines to access indole 2-propargylglycine (isotryptophan) derivatives. o-Alkynylpropargylglycine anilines 5 and 6 were prepared using Sonogashira cross-coupling between o-iodoanilines and enantiopure propargylic glycine precursors. The use of 10 mol% AgOTf in MeCN at reflux for 20 h furnished the isotryptophan products 7 and 8 in good yields. By comparison, the use of a Pd II catalytic system resulted in formation of the undesired cyclization product 9, which was not observed when AgOTf was employed (Scheme 2).

 

In 2007, Li et al. reported a gold and silver co-catalyzed double hydroamination of o-alkynylanilines with terminal alkynes to access N-vinyl indole derivatives.[9] During the catalyst screening process, the separate use of both 5 mol% AgOTf and 5 mol% AgBF4 at 608C for 2 h under neat conditions gave the N-vinyl indole product 12 in 62% and 59% yields, respectively (Scheme 3). Although a silver(I) species can facilitate the cascade hydroamination process alone, it was later revealed that the combination of 5 mol% of AuCl3/AgOTf at RT was more efficient and hence was the main focus of the study.

In 2009, Liu et al. reported a gold and silver co-catalyzed microwave-assisted intramolecular hydroamination of o-alkynylamides to construct N1-carbamide indole derivatives.[10] Although the combination of AuI/AgI in aqueous media using microwave irradiation at 150 8C was chosen as the optimal reaction conditions, using 10 mol% AgOTf or Ag2CO3 alone displayed catalytic activity to afford the cyclized indole product 14 in 23% and 75% yields, respectively (Scheme 4A). It was also found that the reaction conditions were exclusive to o-terminal alkynes as no reaction was observed when 2-substituted o-alkynylcarbamides 15 and 16 were used as substrates(Scheme 4 B).

 

 

In 2009, Ding et al. reported a silver-catalyzed hydroamination process using (o-alkynylphenyl)guanidines 17 to access Ncarboximidamide or N-carboximidoate indole derivatives 18(Scheme 5).[11] By using 5 mol% AgNO3 at RT and MeCN as the solvent, guanidines 17 were found to selectively undergo 5- endo-dig cyclization to afford a range of indole derivatives 18 in good yields. The authors also conducted a comparison study between AgI and other commonly used p-acids such as PdII and CuI salts. It was reported that the reaction using a AgNO3 catalyst was the most effective, proceeding efficiently and in high yield; meanwhile, the analogous reactions using both PdII and CuI catalytic systems were incomplete, even after extended reaction times. Overall, this silver(I)-catalyzed cyclization provides access to N-carboximidamide or N-carboximidoate indole-2-phenyl derivatives under simple and mild reaction conditions.

 

 

In 2010, Oh et al. reported a silver(I)-catalyzed cascade process based on the reaction of o-alkynylformidates 19 and activated methylene compounds 20 to synthesize 3-vinyl indole  derivatives 21(Scheme 6).[12] Typically, these reactions were performed using 5 mol% AgOTf in toluene at 808C for 12 h, enabling a range of 3-vinyl indoles 21 to be prepared in moderate to good yields.

The authors suggested a plausible mechanism for this transformation, involving an interesting 3-alkenyl migration process(Scheme 7). First, coordination of silver(I) to the alkyne facilitates enolate addition into imine 22 to form 23. This is followed by p-acid activation of the alkyne by silver(I) to induce a 5-endo-dig cyclization to form the indole core. 1,3-Alkenyl migration is then proposed to occur via a silver-carbene intermediate 26, which is followed by rapid protodemetallation under acidic conditions to furnish the 3-vinyl indole product 21. Note that similar migration patterns have also been reported by using other transition metals such as PdII, PtII, and AuIII. [5, 13]

 

The 1,3-alkenyl migration mechanism shown in Scheme 7 was supported by a series of control experiments. For example, when o-alkynylenamine 28 was subjected to the standard reaction conditions, only the hydroamination product 29 was isolated in 55% yield (Scheme 8). This suggested that fast protodemetallation was competing with the 1,3-alkenyl migration pathway in some instances.

 

In 2010 Chan et al. described a system for the synthesis of indoles via gold-catalyzed cycloisomerization reactions.[14] During this investigation, as a control experiment, 1,3-diphenyl-1-(2 (tosylamino)phenyl)prop-2-yn-1-ol 30 was treated with 5 mol% AgOTf, which yielded the corresponding indenyl-fused indole 31 in 16% yield, alongside the alcohol-tethered indole 32 in 48% yield (Scheme 9). Although it was proven that AgOTf could facilitate indole formation, a gold-catalyzed method was shown to be more efficient and was the main focus of this investigation.


Two years later, Chan et al. developed a silver-catalyzed tandem heterocyclization/alkynylation process using propargylic 1,4-diols 33 to generate o-alkynyl indoles 34, liberating two molecules of water as the sole by-products (Scheme 10).

 


This was the first reported indole synthesis that introduced alkyne moieties at the 2-position of the indole ring without relying on traditional cross-coupling methods. A variety of tosylprotected o-alkynyl indoles 34, bearing additional substituents in the 3-, 5- and 6-positions, were generated in good to excellent yields employing AgOTf as the catalyst. Interestingly, the reaction proceeds well in the absence of a group in the R 1 position, which leads to the formation of 3H-indole products; this is particularly noteworthy as these products cannot be formed using traditional cross-coupling approaches. The authors suggested that the silver catalyst activates the C@OH bonds in the diol substrates, rather than the alkyne moiety directly, and that this subsequently triggers cyclization/hydroamination.


In 2012, Van der Eycken et al. reported the microwave-assisted syntheses of pyrazino-quinazolines and indolyl-pyrazinones from alkyne-tethered pyrazinones using either silver or gold catalysis.[16] Treatment of alkyne-tethered pyrazinone 35 with AgOTf, using conventional heating, resulted in the synthesis of indole 36 in 18% yield, alongside quinazoline product 37 in 75% yield (Scheme 11). Ag(I) was found to be the superior catalyst for the formation of the quinazoline products, but AuCl was in fact identified as the optimum catalyst for formation of the indole products.

 

In 2012, Tang et al. reported a silver-catalyzed process for the synthesis of bis(indolyl)methanes 40 from o-alkynylanilines 38 and aryl aldehydes 39 (Scheme 12).[17] Their simple one-pot procedure was performed in the presence of 5 mol% AgNO3 in DMSO at 808C for 12 h. A wide range of o-alkynylanilines 38 and aryl aldehydes 39 were tolerated in this process, providing access to the corresponding bis(indolyl)methanes 40 in moderate to excellent yields. Based on previously reported mechanisms, the authors suggested that these reactions proceed via a hydroamination pathway in which the silver catalyst activates both alkyne and aldehyde starting materials.

 

In 2013, Liu et al. reported the synthesis of (3-indolyl)stannanes 42 via a silver-catalyzed cyclization/stannylation cascade process.[18] Starting from a series of o-alkynylanilines 41 and reacting with 5 mol% AgSbF6 and two equivalents of 2-tributylstannylfuran, a wide range of N1-protected-(3-indolyl)stannanes 42 were synthesized (Scheme 13A). The procedure was shown to tolerate both electron-donating and electron-withdrawing groups on the alkyne phenyl ring and substituents at the 4-position of the parent aniline ring. It was found that the presence of an electron-withdrawing protecting group is essential to the success of the reaction, as the non-stannylated 3H-indole product was isolated when a N-methyl aniline starting material was tested. It was also found that indoles bearing electron-withdrawing protecting groups other than sulfonyl were unstable during purification via column chromatography.

 

The authors showcased the utility of the 3-stannylated indole products 42 by performing a series of elaboration reactions. To probe the reaction mechanism, 3H-indole was subjected to the optimized reaction conditions and no stannylated product was observed, which indicated that the stannylation did not occur via C@H functionalization of the indole product but instead through a silver-tin transmetallation process as shown in Scheme 13B. In this mechanism, the silver is proposed to have a dual role; activating the alkyne towards attack from the amino group via the silver-coordinated alkyne 43 whilst also catalyzing the destannylation of 2-tributylstannylfuran throug a transmetallation protodemetallation pathway, thus liberating Bu3Sn+ which goes on to react with the 3-indolyl silver(I) intermediate 44.

 

 

Many indole syntheses utilize silver in mixed catalytic systems :

CAS No. 1000269-51-1

2-Pyridinecarboxylic acid, 5-borono-, 2-(phenylmethyl) ester

Catalog No.:AG0000BX MDL No.:

MF:C13H12BNO4 MW:257.0497

CAS No. 1000269-65-7

2,6,10-TRIAZABICYCLO[9.3.1]PENTADECA-1(15),11,13-TRIENE

Catalog No.:AG0000BW MDL No.:

MF:C12H19N3 MW:205.2994

CAS No. 1000269-66-8

2,5,8,11-TETRAAZABICYCLO[10.3.1]HEXADECA-1(16),12,14-TRIENE

Catalog No.:AG0000BV MDL No.:

MF:C12H20N4 MW:220.3140

CAS No. 1000269-67-9

2,5,9,12-Tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene

Catalog No.:AG0000BU MDL No.:

MF:C13H22N4 MW:234.3406

CAS No. 1000269-68-0

2,6,9,13-TETRAAZABICYCLO[12.3.1]OCTADECA-1(18),14,16-TRIENE

Catalog No.:AG0000BT MDL No.:

MF:C14H24N4 MW:248.3672

CAS No. 100028-43-1

Piperidinium, 1-[2-[cyclohexyl(phenylmethyl)amino]ethyl]-1-methyl-, bromide (1:1)

Catalog No.:AG0000C1 MDL No.:

MF:C21H35BrN2 MW:395.4200

CAS No. 10003-42-6

Glycine, N-[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-

Catalog No.:AG0000C6 MDL No.:

MF:C11H11NO4 MW:221.2093

CAS No. 10003-67-5

1,2,3-Propanetricarboxylic acid, 1,2,3-trinonyl ester

Catalog No.:AG0000C5 MDL No.:

MF:C33H62O6 MW:554.8418

CAS No. 10003-69-7

Acetic acid, 2,2',2'',2'''-[1,2-ethanediylidenetetrakis(thio)]tetrakis-

Catalog No.:AG0000C4 MDL No.:

MF:C10H14O8S4 MW:390.4734

CAS No. 10003-73-3

Benzenemethanamine, 4-amino-, hydrochloride (1:?)

Catalog No.:AG0000C3 MDL No.:

MF:C7H11ClN2 MW:158.6286

CAS No. 10003-95-9

Thymidine 5'-(pentahydrogen tetraphosphate)

Catalog No.:AG0000C2 MDL No.:

MF:C10H18N2O17P4 MW:562.1482

CAS No. 100031-88-7

Silanetriol, [tris(trimethylsilyl)methyl]- (9CI)

Catalog No.:AG0000C0 MDL No.:

MF:C10H30O3Si4 MW:310.6854

CAS No. 100031-92-3

Silanol, 1-[tris(trimethylsilyl)methyl]-

Catalog No.:AG0000BZ MDL No.:

MF:C10H30OSi4 MW:278.6866

CAS No. 100031-98-9

Acetic acid, 2,2,2-trifluoro-, dihydroxy[tris(trimethylsilyl)methyl]silyl ester

Catalog No.:AG0000BY MDL No.:

MF:C12H29F3O4Si4 MW:406.6935

CAS No. 100032-79-9

Hydrazine, (4-bromo-2-nitrophenyl)-, hydrochloride (1:1)

Catalog No.:AG0000CV MDL No.:MFCD09260482

MF:C6H7BrClN3O2 MW:268.4957

CAS No. 100033-28-1

Cyanamide, [4,6-bis(methylamino)-1,3,5-triazin-2-yl]- (9CI)

Catalog No.:AG0000CU MDL No.:

MF:C6H9N7 MW:179.1826

CAS No. 100033-59-8

1-Piperidinamine, N-(1-methylethylidene)-

Catalog No.:AG0000CT MDL No.:

MF:C8H16N2 MW:140.2260

CAS No. 1000333-93-6

1H-Inden-1-one, 6-amino-2,3-dihydro-7-iodo-

Catalog No.:AG0000CS MDL No.:

MF:C9H8INO MW:273.0704

CAS No. 1000335-27-2

4-Pyrimidinamine, 2-chloro-5-methoxy-N-4-piperidinyl-

Catalog No.:AG0000CR MDL No.:

MF:C10H15ClN4O MW:242.7053

CAS No. 1000339-22-9

Benzeneacetic acid, 4,5-difluoro-2-nitro-

Catalog No.:AG0000CQ MDL No.:MFCD09878318

MF:C8H5F2NO4 MW:217.1264

CAS No. 1000339-23-0

4-Pyridinecarboxylic acid, 2-amino-5-bromo-

Catalog No.:AG0000CP MDL No.:MFCD09878357

MF:C6H5BrN2O2 MW:217.0201

CAS No. 1000339-24-1

Benzonitrile, 2-fluoro-3-hydroxy-

Catalog No.:AG0000CO MDL No.:MFCD09839222

MF:C7H4FNO MW:137.1112

CAS No. 1000339-25-2

1,2,4-Oxadiazole, 3-(2-bromophenyl)-5-(2-fluorophenyl)-

Catalog No.:AG0000CN MDL No.:MFCD09878375

MF:C14H8BrFN2O MW:319.1285

CAS No. 1000339-26-3

1,2,4-Oxadiazole, 3-(2-bromophenyl)-5-(2,4-dichlorophenyl)-

Catalog No.:AG0000CM MDL No.:MFCD09878376

MF:C14H7BrCl2N2O MW:370.0282

CAS No. 1000339-27-4

1,2,4-Oxadiazole, 3-(2-bromophenyl)-5-(3-nitrophenyl)-

Catalog No.:AG0000CL MDL No.:MFCD09878377

MF:C14H8BrN3O3 MW:346.1356

CAS No. 1000339-28-5

1,2,4-Oxadiazole, 3-(2-bromophenyl)-5-(2-chlorophenyl)-

Catalog No.:AG0000CK MDL No.:MFCD02217449

MF:C14H8BrClN2O MW:335.5831

CAS No. 1000339-29-6

4(3H)-Quinazolinone, 6-bromo-2-cyclohexyl-

Catalog No.:AG0000CJ MDL No.:MFCD09878379

MF:C14H15BrN2O MW:307.1857

CAS No. 1000339-30-9

Pyrazine, 2-chloro-6-(1-pyrrolidinyl)-

Catalog No.:AG0000CI MDL No.:MFCD09864953

MF:C8H10ClN3 MW:183.6381

CAS No. 1000339-31-0

Piperidine, 1-(3-chloro-4-methylphenyl)-

Catalog No.:AG0000CH MDL No.:MFCD09878387

MF:C12H16ClN MW:209.7151

CAS No. 1000339-32-1

Pyrrolidine, 1-(5-fluoro-2-methylphenyl)-

Catalog No.:AG0000CG MDL No.:MFCD09878397

MF:C11H14FN MW:179.2340

CAS No. 1000339-33-2

Pyrrolidine, 1-(3-chloro-4-fluorophenyl)-

Catalog No.:AG0000CF MDL No.:MFCD09878399

MF:C10H11ClFN MW:199.6524

CAS No. 1000339-34-3

1H-1,2,3-Triazole-4-methanol, 1-(4-bromophenyl)-α,α-dimethyl-

Catalog No.:AG0000CE MDL No.:MFCD09878410

MF:C11H12BrN3O MW:282.1365

CAS No. 1000339-35-4

Benzenesulfonamide, 5-bromo-N-cyclopropyl-2-methoxy-

Catalog No.:AG0000CD MDL No.:MFCD08235093

MF:C10H12BrNO3S MW:306.1762

CAS No. 1000339-36-5

Benzenesulfonamide, N-ethyl-N-[(4-methoxyphenyl)methyl]-

Catalog No.:AG0000CC MDL No.:MFCD09878415

MF:C16H19NO3S MW:305.3920

CAS No. 1000339-45-6

Butanoic acid, 2,2-difluoro-, butyl ester

Catalog No.:AG0000CB MDL No.:MFCD09954718

MF:C8H14F2O2 MW:180.1924

CAS No. 1000339-51-4

Benzoic acid, 3-fluoro-2-nitro-

Catalog No.:AG0000CA MDL No.:MFCD07368342

MF:C7H4FNO4 MW:185.1094

CAS No. 1000339-52-5

3-Fluoro-2-nitrobenzonitrile

Catalog No.:AG0000C9 MDL No.:MFCD09864664

MF:C7H3FN2O2 MW:166.1093

CAS No. 1000339-54-7

Benzaldehyde, 2-methoxy-3-(trifluoromethyl)-

Catalog No.:AG0000C8 MDL No.:MFCD08741399

MF:C9H7F3O2 MW:204.1459

CAS No. 1000339-55-8

Benzaldehyde, 3-methyl-5-(trifluoromethoxy)-

Catalog No.:AG0000C7 MDL No.:MFCD08741401

MF:C9H7F3O2 MW:204.1459

CAS No. 1000339-73-0

Thiazole, 5-(bromomethyl)-2-methyl-4-(trifluoromethyl)-

Catalog No.:AG0000DF MDL No.:MFCD09264554

MF:C6H5BrF3NS MW:260.0748

CAS No. 1000339-92-3

Benzeneacetonitrile, 2-fluoro-5-nitro-

Catalog No.:AG0000DE MDL No.:MFCD09864689

MF:C8H5FN2O2 MW:180.1359

CAS No. 1000339-93-4

Benzonitrile, 4-fluoro-2-(hydroxymethyl)-

Catalog No.:AG0000DD MDL No.:MFCD09864693

MF:C8H6FNO MW:151.1377

CAS No. 1000339-94-5

Phenol, 3-chloro-4-(trifluoromethoxy)-

Catalog No.:AG0000DC MDL No.:MFCD04972754

MF:C7H4ClF3O2 MW:212.5537

CAS No. 1000339-98-9

1H-Indazole, 4-(trifluoromethyl)-

Catalog No.:AG0000DB MDL No.:MFCD09263211

MF:C8H5F3N2 MW:186.1339

CAS No. 1000340-01-1

Pyridine, 3,5-dibromo-2-fluoro-4-methyl-

Catalog No.:AG0000DA MDL No.:MFCD09864703

MF:C6H4Br2FN MW:268.9091

CAS No. 1000340-11-3

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-bromo-6-methyl-

Catalog No.:AG0000D9 MDL No.:MFCD09880100

MF:C9H7BrN2O2 MW:255.0681

CAS No. 1000340-12-4

1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-chloro-6-methyl-

Catalog No.:AG0000D8 MDL No.:

MF:C9H7ClN2O2 MW:210.6171

CAS No. 1000340-13-5

1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 5-chloro-6-methyl-

Catalog No.:AG0000D7 MDL No.:

MF:C9H7ClN2O MW:194.6177

CAS No. 1000340-14-6

1H-Pyrrolo[2,3-b]pyridin-3-amine, 5-chloro-6-methyl-

Catalog No.:AG0000D6 MDL No.:

MF:C8H8ClN3 MW:181.6222

CAS No. 1000340-15-7

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-6-methyl-3-nitro-

Catalog No.:AG0000D5 MDL No.:

MF:C8H6ClN3O2 MW:211.6051

CAS No. 1000340-16-8

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-3-iodo-6-methyl-

Catalog No.:AG0000D4 MDL No.:MFCD09880105

MF:C8H6ClIN2 MW:292.5041

CAS No. 1000340-17-9

1H-Pyrrolo[2,3-b]pyridine, 3-bromo-5-chloro-6-methyl-

Catalog No.:AG0000D3 MDL No.:MFCD09880106

MF:C8H6BrClN2 MW:245.5036

CAS No. 1000340-18-0

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-6-methyl-

Catalog No.:AG0000D2 MDL No.:MFCD09880081

MF:C8H7ClN2 MW:166.6076

CAS No. 1000340-19-1

1H-Pyrrolo[2,3-b]pyridine, 6-methyl-5-nitro-

Catalog No.:AG0000D1 MDL No.:

MF:C8H7N3O2 MW:177.1601

CAS No. 1000340-20-4

1H-Pyrrolo[2,3-b]pyridine, 3-bromo-6-methyl-5-nitro-

Catalog No.:AG0000D0 MDL No.:

MF:C8H6BrN3O2 MW:256.0561

CAS No. 1000340-21-5

1H-Pyrrolo[2,3-b]pyridine, 3-iodo-6-methyl-5-nitro-

Catalog No.:AG0000CZ MDL No.:

MF:C8H6IN3O2 MW:303.0566

CAS No. 1000340-22-6

1H-Pyrrolo[2,3-b]pyridin-3-amine, 6-methyl-5-nitro-

Catalog No.:AG0000CY MDL No.:

MF:C8H8N4O2 MW:192.1747

CAS No. 1000340-23-7

1H-Pyrrolo[2,3-b]pyridin-5-amine, 6-methyl-3-nitro-

Catalog No.:AG0000CX MDL No.:MFCD09880111

MF:C8H8N4O2 MW:192.1747

CAS No. 1000340-24-8

1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 6-methyl-5-nitro-

Catalog No.:AG0000CW MDL No.:

MF:C9H7N3O3 MW:205.1702

CAS No. 1000342-68-6

1H-Pyrrolo[3,2-c]pyridine, 4-bromo-

Catalog No.:AG0000KH MDL No.:MFCD08690131

MF:C7H5BrN2 MW:197.0320

CAS No. 1000342-69-7

1H-Pyrrolo[3,2-c]pyridine-3-carboxaldehyde, 4-methyl-

Catalog No.:AG0000KG MDL No.:

MF:C9H8N2O MW:160.1726

CAS No. 1000342-70-0

1H-Indazol-4-amine, 6-bromo-3-iodo-

Catalog No.:AG0000KF MDL No.:

MF:C7H5BrIN3 MW:337.9432

CAS No. 1000342-71-1

1H-Pyrrolo[3,2-c]pyridine, 6-bromo-

Catalog No.:AG0000KE MDL No.:MFCD08690134

MF:C7H5BrN2 MW:197.0320

CAS No. 1000342-72-2

1H-Pyrrolo[3,2-c]pyridine, 3-bromo-4-methyl-

Catalog No.:AG0000KD MDL No.:MFCD09749964

MF:C8H7BrN2 MW:211.0586

CAS No. 1000342-73-3

1H-Indol-4-ol, 6-bromo-2,3-dihydro-

Catalog No.:AG0000KC MDL No.:

MF:C8H8BrNO MW:214.0592

CAS No. 1000342-74-4

1H-Pyrrolo[3,2-c]pyridin-6-amine

Catalog No.:AG0000KB MDL No.:MFCD08690136

MF:C7H7N3 MW:133.1506

CAS No. 1000342-75-5

1H-Pyrrolo[3,2-c]pyridine-3-carboxylic acid, 4-methyl-

Catalog No.:AG0000KA MDL No.:

MF:C9H8N2O2 MW:176.1720

CAS No. 1000342-77-7

1H-Pyrrolo[3,2-c]pyridine, 6-nitro-

Catalog No.:AG0000K9 MDL No.:

MF:C7H5N3O2 MW:163.1335

CAS No. 1000342-78-8

1H-Pyrrolo[3,2-c]pyridine, 3-iodo-6-methyl-

Catalog No.:AG0000K8 MDL No.:MFCD09749966

MF:C8H7IN2 MW:258.0591

CAS No. 1000342-80-2

2H-Pyrrolo[3,2-c]pyridin-2-one, 6-chloro-1,3-dihydro-

Catalog No.:AG0000K7 MDL No.:MFCD08690138

MF:C7H5ClN2O MW:168.5804

CAS No. 1000342-81-3

1H-Pyrrolo[3,2-c]pyridine, 6-broMo-4-Methoxy-

Catalog No.:AG0000K6 MDL No.:MFCD09749967

MF:C8H7BrN2O MW:227.0580

CAS No. 100208-31-9

2-Oxiraneoctanoic acid, 3-[[3-[(3-ethyl-2-oxiranyl)methyl]-2-oxiranyl]methyl]-, hexyl ester

Catalog No.:AG00019S MDL No.:

MF:C24H42O5 MW:410.5873

CAS No. 10021-55-3

Benzenesulfonic acid, 2,5-dihydroxy-, sodium salt (1:1)

Catalog No.:AG00019W MDL No.:MFCD00065077

MF:C6H5NaO5S MW:212.1557

CAS No. 10021-64-4

Butanenitrile, 2-hydroxy-3-methyl-, (2R)-

Catalog No.:AG00019V MDL No.:

MF:C5H9NO MW:99.1311

CAS No. 10021-67-7

2-Thiophenemethanol, α-(aminomethyl)-, (αS)-

Catalog No.:AG00019U MDL No.:MFCD04038402

MF:C6H9NOS MW:143.2068

CAS No. 10021-77-9

Acetyl chloride, 2,2'-dithiobis-

Catalog No.:AG00019T MDL No.:

MF:C4H4Cl2O2S2 MW:219.1094

CAS No. 100214-79-7

CL 205086 (9CI)

Catalog No.:AG0001A8 MDL No.:MFCD00091827

MF:C3H3N3O2 MW:113.0748

CAS No. 100214-87-7

Docosanoic acid, ester with 1,2-propanediol

Catalog No.:AG0001A7 MDL No.:

MF:C25H52O4 MW:416.6780

CAS No. 100216-90-8

Benzamide, 3-cyano-N-hydroxy-N-phenyl-

Catalog No.:AG0001A6 MDL No.:

MF:C14H10N2O2 MW:238.2414

CAS No. 100219-26-9

3-Octanone, 4-bromo-2,2-dimethyl-8-phenoxy-

Catalog No.:AG0001A5 MDL No.:

MF:C16H23BrO2 MW:327.2566

CAS No. 10022-13-6

β-D-Glucopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-, 1,3,4,6-tetraacetate

Catalog No.:AG0001AJ MDL No.:MFCD00080781

MF:C22H23NO11 MW:477.4181

CAS No. 10022-28-3

Octane, 1,1-dimethoxy-

Catalog No.:AG0001AI MDL No.:MFCD00036644

MF:C10H22O2 MW:174.2805

CAS No. 10022-47-6

Sulfuric acid, ammonium chromium(3+) salt (2:1:1), dodecahydrate (8CI,9CI)

Catalog No.:AG0001AG MDL No.:

MF: MW:

CAS No. 10022-50-1

Nitryl fluoride ((NO2)F)

Catalog No.:AG0001AF MDL No.:

MF: MW:

CAS No. 10022-55-6

2,8,9-Trioxa-5-aza-1-phosphabicyclo[3.3.3]undecane, 1-oxide

Catalog No.:AG0001AE MDL No.:

MF:C6H12NO4P MW:193.1375

CAS No. 10022-60-3

Hexanedioic acid, 1,6-bis(2-ethylbutyl) ester

Catalog No.:AG0001AD MDL No.:

MF:C18H34O4 MW:314.4602

CAS No. 10022-79-4

3H-Pyrido[3,4-b]indole, 4,9-dihydro-1-phenyl-

Catalog No.:AG0001AB MDL No.:

MF:C17H14N2 MW:246.3065

CAS No. 10022-80-7

3H-Pyrido[3,4-b]indole, 4,9-dihydro-1-(phenylmethyl)-

Catalog No.:AG0001AA MDL No.:

MF:C18H16N2 MW:260.3330

CAS No. 10022-82-9

3H-Pyrido[3,4-b]indole-3-carboxylic acid, 4,9-dihydro-1-methyl-

Catalog No.:AG0001A9 MDL No.:

MF:C13H12N2O2 MW:228.2466

CAS No. 100220-48-2

Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, oxime

Catalog No.:AG0001A4 MDL No.:

MF:C11H9Cl2N3O MW:270.1147

CAS No. 1002202-35-8

2-Propenamide, 3-(3-methoxyphenyl)-N-(4-methoxyphenyl)-, (2E)-

Catalog No.:AG00019X MDL No.:

MF:C17H17NO3 MW:283.3218

CAS No. 100221-90-7

Benzamide, 2-bromo-N-[2-[4-(phenylmethyl)-1-piperazinyl]ethyl]-

Catalog No.:AG0001A3 MDL No.:

MF:C20H24BrN3O MW:402.3281

CAS No. 100222-34-2

5-Dodecen-7-yne, 6-(2-propenyl)-, (E)- (9CI)

Catalog No.:AG0001A2 MDL No.:

MF:C15H24 MW:204.3511

CAS No. 100222-98-8

Hexanoic acid, 6-[[(1,1-dimethylethoxy)carbonyl]methylamino]-

Catalog No.:AG0001A1 MDL No.:

MF:C12H23NO4 MW:245.3153

CAS No. 100223-15-2

Pyrrolo[2,3-b]carbazole, 1,9-dihydro-

Catalog No.:AG0001A0 MDL No.:

MF:C14H10N2 MW:206.2426

CAS No. 100223-28-7

Pyridazine, 3-chloro-6-[4-(2,3-dimethylphenyl)-1-piperazinyl]-

Catalog No.:AG00019Z MDL No.:

MF:C16H19ClN4 MW:302.8019

CAS No. 100224-52-0

1-Piperazinecarboxylic acid, 4-(6-chloro-3-pyridazinyl)-, ethyl ester

Catalog No.:AG00019Y MDL No.:

MF:C11H15ClN4O2 MW:270.7154

CAS No. 1002243-79-9

1H-Pyrazole-1-propanenitrile, 4-nitro-

Catalog No.:AG0001AT MDL No.:MFCD02029339

MF:C6H6N4O2 MW:166.1374

CAS No. 1002304-34-8

Quinoline, 7-methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]-

Catalog No.:AG0001AS MDL No.:MFCD17215205

MF:C22H17N5O2 MW:383.4027

CAS No. 1002309-19-4

1H-Isoindol-1-one, 2,3-dihydro-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AR MDL No.:MFCD14706581

MF:C15H20BNO3 MW:273.1352

CAS No. 1002309-47-8

Benzothiazole, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AQ MDL No.:MFCD12408395

MF:C13H16BNO2S MW:261.1476

CAS No. 1002309-48-9

1H-Pyrazole, 1-cyclobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AP MDL No.:MFCD16659010

MF:C13H21BN2O2 MW:248.1290

CAS No. 1002309-52-5

2(1H)-PYRIDINONE, 1-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-

Catalog No.:AG0001AO MDL No.:MFCD11044683

MF:C12H18BNO3 MW:235.0872

CAS No. 100231-78-5

Phosphonium, tetrakis(hydroxymethyl)-, phosphate (2:1) (salt) (9CI)

Catalog No.:AG0001AU MDL No.:

MF:C8H25O12P3 MW:406.1982

CAS No. 1002334-06-6

1H-Pyrazole, 1-methyl-3-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AN MDL No.:MFCD16659793

MF:C16H21BN2O2 MW:284.1611

CAS No. 1002334-09-9

1H-Pyrazole, 4-butyl-1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AM MDL No.:

MF:C19H27BN2O2 MW:326.2409

CAS No. 1002334-12-4

1H-Pyrazole, 1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AL MDL No.:MFCD12400941

MF:C15H19BN2O2 MW:270.1346

CAS No. 1002334-13-5

1H-Pyrazole, 1-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0001AK MDL No.:MFCD16659786

MF:C15H19BN2O2 MW:270.1346

© 2019 Angene International Limited. All rights Reserved.